CYTOSORBENTS CORP
CTSO·23283X206·US·Common Stock·Healthcare - Medical Devices-13D/G
CTSO (CYTOSORBENTS CORP) is held by 37 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.1M), Neuberger Berman Group LLC ($950,776), BlackRock, Inc. ($443,408). Net institutional sentiment: Mixed.
37
Holders
Avg rating(12 Elite)
$4.1M
Total Value
58% (40)
Fund Consensus
15 buying - 11 selling
Who's Trading
InsiderMJMARIANI PETER JBuy $44KJun 15, 2026
ActivistAVAVENIR CORP8.3%Feb 13, 2026
ActivistAVAvenue Venture Opportunities Fund, L.P.1.7%May 28, 2025
ActivistSKSkylands Capital, LLC4.8%Apr 17, 2025
13F: Insider & Congress:
Showing 1-20 of 40
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer